Therapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Compulsive Disorder (OCD)

July 31, 2023 updated by: Kate Harvey, University of Reading

This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.

Specifically, this study aims to:

  1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
  2. Examine parents' experiences and views about the acceptability of the treatment approach.

Study Overview

Detailed Description

This study adapted an existing therapist guided, parent-led CBT intervention for children with anxiety difficulties, to ensure suitability for preadolescent children with OCD.

This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.

Specifically, this study aims to:

  1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
  2. Examine parents' experiences and views about the acceptability of the treatment approach.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • UK
      • Reading, UK, United Kingdom, RG6 6BZ
        • University of Reading

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Children

Inclusion criteria:

  1. Aged 5 to 12 years old (when parents/carers complete the baseline questionnaires).
  2. Diagnosis of OCD (identified from the ADIS-P).
  3. UK-resident. Parents

Inclusion criteria:

  1. Parent/legal guardian of the child.
  2. UK resident.

Exclusion Criteria:

Children

Exclusion criteria:

  1. Comorbid condition, which is likely to interfere with treatment delivery, for example:

    1. Established Autism Spectrum Condition (ASC).
    2. Suspected ASC (indicated by exceeding the threshold of 15 on the Social Communication Questionnaire and where a diagnosis of ASC has not been ruled out by a medical professional).
    3. Profound learning difficulty (evidenced by attending a specialist school).
  2. Risk and/or safeguarding concerns, which are paramount and would interfere with treatment delivery, for example:

    1. Suicidal intent.
    2. Recurrent or potentially life limiting self-harm.
    3. Significant safeguarding concerns (i.e., if the child has a child protection plan and/or is on the child protection register, and/or the research team consider the child to be suffering, or likely to suffer, significant harm).
  3. If children have been prescribed psychotropic medication, the dosage must have been stable for two months.
  4. Children who are currently receiving other psychological support/interventions delivered by a mental health professional.

Parents

Exclusion criteria:

  1. Significant intellectual impairment that is likely to interfere with treatment delivery.
  2. Unable to access or understand written English language materials needed for the intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapist guided, parent-led CBT for preadolescent children with OCD
6 to 8 sessions of therapist guided, parent-led CBT for preadolescent children with OCD
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Children's Yale Brown Obsessive Compulsive Scale (CY-BOCS)
Time Frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Diagnostic interview. Higher scores indicate higher severity of OCD
Change from pre-baseline phase, within one-week post-treatment, one-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety Disorder Interview Schedule - Parent Report (ADIS-P)
Time Frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Diagnostic interview. Indicates presence/absence of anxiety, OCD, and externalising difficulties. Higher severity scores indicate greater severity of difficulties.
Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Children's Obsessional Compulsive Inventory - Revised - Parent Report (ChOCI-R-P)
Time Frame: Weekly during baseline and intervention phase; one month follow up
Symptom measure. Higher scores indicate greater OCD symptoms and impairment.
Weekly during baseline and intervention phase; one month follow up
Family Accommodation Scale - FAS
Time Frame: Weekly during baseline and intervention phase; one month follow up
Symptom measure. Higher scores indicate greater levels of family accommodation of OCD.
Weekly during baseline and intervention phase; one month follow up
Goal Based Outcomes - GBOs
Time Frame: Weekly during intervention phase; one month follow up
Families identify up to 3 personalised goals to work towards during the intervention. Goals are rated weekly by the parent form 0 (no goal progress) to 10 (goal achieved)
Weekly during intervention phase; one month follow up
Session Rating Scale- SRS
Time Frame: Weekly during intervention phase; one month follow-up
Therapeutic alliance/treatment acceptability. Higher scores indicate greater acceptability.
Weekly during intervention phase; one month follow-up
Treatment acceptability questions
Time Frame: one month follow-up
Treatment acceptability. 6 questionnaire items on a Likert scale from strongly disagree to strongly agree. 4 open ended questions regarding treatment acceptability.
one month follow-up
Items assessing parent knowledge of OCD, how to help their child, and confidence to help child
Time Frame: Weekly during baseline and intervention phase; one month follow up
3 questionnaire items devised by study authors to assess parents' report of their knowledge and confidence to help their child to overcome OCD. Items scored from 0 (no new learning) to 5 (learned a lot)
Weekly during baseline and intervention phase; one month follow up
Items assessing how much children have learned new information about their fears/ability to cope in feared situations
Time Frame: Weekly during intervention phase; one month follow up
2 questionnaire items devised by study authors to assess parents' perceptions of whether their child had learned new information about their fears and their ability to cope in feared situations, without performing their compulsions. Items scored from 0 (no new learning) to 5 (learned a lot)
Weekly during intervention phase; one month follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kate N Harvey, PhD, University of Reading

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2021

Primary Completion (Actual)

March 3, 2022

Study Completion (Actual)

March 28, 2022

Study Registration Dates

First Submitted

July 18, 2023

First Submitted That Met QC Criteria

July 31, 2023

First Posted (Actual)

August 8, 2023

Study Record Updates

Last Update Posted (Actual)

August 8, 2023

Last Update Submitted That Met QC Criteria

July 31, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We are not able to make individual participant data available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on OCD

3
Subscribe